Vascepa and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Vascepa (icosapent ethyl), especially for people who are female, 60+ old, also take Nasonex, and have Blood disorder.

The phase IV clinical study analyzes which people have Tumor when taking Vascepa. It is created by eHealthMe based on reports of 5,777 people who have side effects when taking Vascepa from the FDA, and is updated regularly.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.

What is Tumor?

Tumor is found to be associated with 1,418 drugs and 1,704 conditions by eHealthMe. Check the latest studies of Tumor.

On Jul, 19, 2026

5,777 people reported to have side effects when taking Vascepa.
Among them, 13 people (0.23%) have Tumor.

Among these 13 people:

What is the gender of people who have Tumor when taking Vascepa? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Tumor when taking Vascepa? *

What are other drugs people take besides Vascepa? *

What are other side effects people have besides Tumor? *

Headache (pain in head): 9 people, 69.23%
Stress And Anxiety: 7 people, 53.85%
Fatigue (feeling of tiredness): 7 people, 53.85%
Insomnia (sleeplessness): 5 people, 38.46%
Pain: 5 people, 38.46%
Muscle Spasms (muscle contraction): 5 people, 38.46%
Sneezing: 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Fall: 4 people, 30.77%
Nausea And Vomiting: 4 people, 30.77%

What are the existing conditions these people have? *

Blood Disorder: 3 people, 23.08%
Hiv Infection: 2 people, 15.38%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Prostate Cancer: 1 person, 7.69%
Primary Immunodeficiency Syndrome: 1 person, 7.69%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.69%
Fatigue (feeling of tiredness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vascepa and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vascepa:

Vascepa (5,894 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Vascepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,418 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,704 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on icosapent ethyl (the active ingredients of Vascepa) and Vascepa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.